Skip to main content

Software and artificial intelligence (AI)

We regulate software-based devices (including AI) that work to achieve a therapeutic purpose in human beings.

An overview of software and artificial intelligence

Regulation of software and artificial intelligence

Know your obligations at each point along your product’s regulatory journey.

  • Icon - manufacturing

    Manufacturing

    Search guidance and other information on manufacturing for software and artificial intelligence (AI).

  • icon - application and market authorisation

    Application and market authorisation

    Guidance and other information on the application process, including evaluation processes and fees, for software and artificial intelligence (AI).

  • icon - supply and distribution

    Supply and distribution

    Find requirements for the ongoing supply, import, export, storage and handling of software and artificial intelligence (AI).

  • icon - labelling and advertising

    Labelling and advertising

    Information about labelling, packaging and advertising for software and artificial intelligence (AI).

  • icon - monitoring and compliance

    Monitoring and compliance

    Understand your ongoing post-market responsibilities for software and artificial intelligence (AI) products.

Latest alerts

  • Product correction: Ypsomed Australia is reminding users to ensure they use a compatible smart device and operating system (OS) when using the Mylife CamAPS FX app.

Open consultations

Articles

  • We have published our Clarifying and strengthening the regulation of Medical Device Software including Artificial Intelligence (AI) report.
  • The 3G network shutdown may impact certain medical devices. Consumers, healthcare providers, manufacturers, and suppliers should take precautions to prevent disruption in essential medical services.

Latest publications